KALA · KALA BIO, Inc.
$0.67
+0.01 (+1.94%)
At close · Jul 29
Market Cap
$12.52M
Shares
18.59M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$26.98M
+29.9%
FY2025
Operating Margin
-2099.33%
-940.6pp
FY2022
Diluted EPS
-$165.50
+67.4%
FY2025
Operating Cash Flow
-$31.99M
-8.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $0 | $0 | $0 | $3.89M | $11.24M | $6.36M | $6.07M | — | $0 | $0 | $45K | |
| $12.79M | $18.78M | $22.09M | $18.59M | $17.65M | $11.52M | $18.35M | $27.28M | $29.29M | $29.01M | $25.03M | $11.38M | |
| $20.78M | $23.63M | $18.34M | $20.57M | — | — | — | — | — | $10.87M | $7.64M | $4.61M | |
| — | — | — | $20.57M | $65.04M | $105.06M | $81.07M | $65.02M | $35.43M | $10.87M | — | — | |
| — | $317K | $259K | $303K | $537K | $975K | $912K | $843K | — | — | — | — | |
| $30.29M | $39.16M | $40.98M | $39.66M | $85.6M | $141.49M | $102.59M | $94.3M | $64.72M | $39.88M | $32.67M | $15.99M | |
| -$30.29M | -$39.16M | -$40.98M | -$39.66M | -$81.71M | -$130.25M | -$96.23M | -$88.22M | -$64.72M | -$39.88M | -$32.67M | -$15.95M | |
| — | — | — | — | -2099.33% | -1158.76% | -1512.59% | -1452.49% | — | — | — | -35435.56% | |
| — | -$38.84M | -$40.72M | -$39.36M | -$81.17M | -$129.27M | -$95.32M | -$87.38M | — | — | — | — | |
| — | $3.28M | $5.78M | $5.81M | $7.27M | $8.38M | $8.59M | $8.48M | $3.31M | $1.02M | $767K | $604K | |
| $751K | $1.14M | $2.06M | $2.71M | $664K | $104K | $493K | $2.36M | $1.69M | $527K | $147K | — | |
| $10.64M | $12.18M | $2.47M | -$2.54M | $36.88M | -$12.36M | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| -$19.65M | -$26.98M | -$38.51M | -$42.2M | -$44.82M | -$142.61M | -$104.33M | -$94.35M | -$66.74M | -$42.21M | -$33.17M | -$16.68M | |
| — | — | — | — | -1151.64% | -1268.73% | -1639.85% | -1553.29% | — | — | — | -37071.11% | |
| -$19.65M | -$26.98M | -$38.51M | -$42.2M | -$44.82M | -$142.61M | -$104.32M | -$94.35M | — | — | — | — | |
| USD/shares | — | -$165.50 | -$507.50 | -$867.50 | -$1,474.00 | -$5,416.00 | -$4,975.00 | — | — | — | — | — |
| USD/shares | — | -$165.50 | -$507.50 | -$867.50 | -$1,474.00 | -$5,416.00 | -$4,975.00 | — | — | — | — | — |
| shares | — | 162.97K | 75.92K | 48.64K | 30.41K | 26.33K | 20.95K | 13.68K | 10.7K | 4550 | 472.5716 | 448.1072 |
| shares | — | 162.97K | 75.92K | 48.64K | 30.41K | 26.33K | 20.95K | 13.68K | 10.7K | 4550 | 472.5716 | 448.1072 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 0.04×
Peer medians compare against the 207 similar-size Biotechnology companies (of 522 listed).